About Us
Who
We Are
Founded in 2018 as a subsidiary of ArtemiFlow GmbH in Potsdam, Germany, ArtemiFlow USA is a technology-based manufacturing company specializing in the production of Artemisia annua, artemisinin, and artemisinin-derivatives. We are dedicated to revolutionizing the pharmaceutical industry by implementing innovative technologies and sustainable practices throughout the entire value chain.
Our
Vision
Our vision is to become a global leader in artemisinin-derivative drugs for all known and emerging applications. By utilizing untapped potential across the entire production process and employing state-of-the-art technologies, we aim to make life-saving medications more accessible and affordable worldwide.
Our
Journey
Since our inception, we have been committed to capturing the entire value chain of drug production within the United States. From cultivating high-yielding varieties of Artemisia annua to extracting artemisinin using environmentally friendly methods and converting it into its derivatives through patented continuous processes, we ensure unmatched quality and efficiency.
Our collaboration with the University of Kentucky Tobacco Research & Development Center (KTRDC) since 2017 has been instrumental in optimizing the cultivation and harvesting processes of Artemisia annua. By bringing a traditionally Chinese-grown crop to the United States and scaling its production using advanced American agriculture, we are fostering innovation and creating new opportunities here in the US.
